
Therefore, steroids like dexamethasone are prescribed to treat cytokine storms in COVID-19 patients. COVID-19 Fourth Wave: India Reports Over 15,000 New COVID Cases In 24 Hours.COVID-19 LIVE UPDATES: India Logs Nearly 1 Lakh COVID Cases In a Week, Death Toll Reaches 100.India Witnesses A New High In COVID Cases: Pain In These Areas Is A Sign To Look Out For.In fact, cytokine storm has been linked to mortality in COVID-19 patients. Cytokines play an important role in normal immune responses, too many of them can lead to hyperinflammation and tissue damage. This occurs when the body releases too many cytokines into the blood too quickly known as cytokine storm. This is a severe complication of respiratory infections, like influenza and COVID-19, resulting from exaggerated immune response to the viruses. Dexamethasone has been used to treat acute respiratory distress syndrome (ARDS) or worsening of lung inflammation. Steroids are anti-inflammatory medicines that are typically used to treat rheumatologic diseases, like rheumatoid arthritis, lupus or vasculitis (inflammation of the blood vessels). Why steroids are prescribed for COVID-19 patients? These drugs can backfire in patients whose immune response is already suppressed, they stated in the study published in the journal Science Advances. In addition, corticosteroids, commonly referred to as steroids, are allowed for treatment of coronavirus patients in moderate to severe stages of illness.īut a new study has cautioned that steroids such as dexamethasone should be reserved for the sickest COVID-19 patients. In India, the Union health ministry has included antiviral drug remdesivir, arthritis drug tocilizumab, anti-malarial drug hydroxychloroquine in the treatment protocols for COVID-19 patients under the 'investigational therapy'. In the absence of a cure or vaccine for COVID-19, medical professionals are trying to repurpose existing drugs to treat the new disease. Written by Longjam Dineshwori | Updated : Novem9:42 AM IST

Dexamethasone and other steroids can backfire in COVID-19 patients whose immune response is already suppressed, warn researchers.
